Professor at Jeonnam National University Hospital Selected for Korean Society of Cardiology Young Investigator Award for 'Brugada Treatment'

Professor Jeong Hyung-gi of the Department of Cardiology, Research on Hereditary Arrhythmia Disease

[Asia Economy Honam Reporting Headquarters Reporter Lee Gwan-woo] Professor Jeong Hyeong-gi of the Department of Cardiology at Chonnam National University Hospital was recently selected for the Korean Society of Cardiology's '2020 New Researcher Award' for his study on a new treatment for Brugada syndrome, a hereditary arrhythmia disease.

According to Chonnam National University Hospital on the 24th, the selected research is titled "Antiarrhythmic effect of artemisinin in canine experimental model of Brugada syndrome," focusing on the effect of artemisinin in suppressing ventricular arrhythmia.

The research funding supported by the Korean Society of Cardiology amounts to a total of 30 million KRW over two years.

Brugada syndrome is a hereditary arrhythmia disease that can cause sudden death in healthy adults without any specific structural abnormalities of the heart, accounting for 5-10% of all sudden deaths.

So far, the pathophysiology of Brugada syndrome has been suggested to involve abnormalities in myocardial depolarization and repolarization, and artemisinin, a drug used to treat malaria, has been reported to potentially inhibit the function of ion channels involved in repolarization abnormalities.

Professor Jeong will conduct research on the antiarrhythmic effects of artemisinin.

Currently, the drugs used to treat Brugada syndrome are very limited, and there are difficulties in their use due to side effects that require careful administration.

However, this research is expected to suggest the possibility of safely administering drug treatment to patients with Brugada syndrome.

This content was produced with the assistance of AI translation services.